Target intelligence / Profile preview

Long intergenic non-protein coding RNA 954 (LINC00954)

Target
LINC00954
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 954 (LINC00954) is a human long non-coding RNA (lncRNA) classified specifically as a long intergenic non-coding RNA (lincRNA), meaning it is a non-protein-coding transcript over 200 nucleotides in length that does not overlap protein-coding genes[1][5]. LINC00954 is usually treated as a non-coding regulatory RNA, but recent evidence shows it contains a small open reading frame (smORF) that encodes a short 49-amino acid polypeptide, LINC00954-ORF, which may have biological (tumor-suppressive) function in lung adenocarcinoma cells by reducing proliferation, invasion, and sensitizing cells to the chemotherapeutic pemetrexed by regulating proteins such as PCNA and CDK1[2]. While such polypeptides suggest coding potential, the primary role assigned to LINC00954 remains gene and chromatin regulation. LINC00954 and its encoded peptide are not currently established as actionable drug targets or therapeutic receptors.

Other names
FLJ12334LINC00954
02

Mechanism of action

Sensitization to chemotherapeutic agents (e.g., sensitizing lung adenocarcinoma cells to pemetrexed via a peptide encoded by a small ORF within LINC00954)

03

Biological functions

Regulation of gene expressionChromatin remodelingTranscription regulationRNA processingTumor suppression (context-dependent)Modulation of cell proliferation and invasion
04

Disease associations

Cancer (including lung adenocarcinoma)Other (potential roles in cell growth control, subject to continued research)
05

Safety considerations

No established therapeutic usage or associated safety concerns as a direct drug target; potential off-target or unknown effects if used as therapeutic; further research needed
06

Interacting drugs

Pemetrexed (only in experimental context, not direct targeting but modulation of sensitivity)
07

Biomarkers

Expression of LINC00954-ORF peptide in certain cancers may serve as biomarker for sensitivity to pemetrexed or tumor suppression (experimental context only)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 954 (LINC00954).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 954 (LINC00954).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call